A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection

42Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP.

Cite

CITATION STYLE

APA

López-Saavedra, A., Gómez-Cabello, D., Domínguez-Sánchez, M. S., Mejías-Navarro, F., Fernández-Ávila, M. J., Dinant, C., … Huertas, P. (2016). A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection. Nature Communications, 7. https://doi.org/10.1038/ncomms12364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free